Cargando…

Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture

A series of novel amphiphilic macromolecules composed of alkyl chains as the hydrophobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively charged moieties (ie, carb...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinzhong, Plourde, Nicole M, Iverson, Nicole, Moghe, Prabhas V, Uhrich, Kathryn E
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676825/
https://www.ncbi.nlm.nih.gov/pubmed/18203436
_version_ 1782166774927589376
author Wang, Jinzhong
Plourde, Nicole M
Iverson, Nicole
Moghe, Prabhas V
Uhrich, Kathryn E
author_facet Wang, Jinzhong
Plourde, Nicole M
Iverson, Nicole
Moghe, Prabhas V
Uhrich, Kathryn E
author_sort Wang, Jinzhong
collection PubMed
description A series of novel amphiphilic macromolecules composed of alkyl chains as the hydrophobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively charged moieties (ie, carboxylic acids) located in the two different blocks. The macromolecules have molecular weights around 5,500 g/mol, form micelles in aqueous solution with an average size of 20–35 nm, and display critical micelle concentration values as low as 10(−7) M. Their charge densities and hydrodynamic size in physiological buffer solutions correlated with the hydrophobic/hydrophilic block location and quantity of the carboxylate groups. Generally, carboxylate groups located in the hydrophobic block destabilize micelle formation more than carboxylate groups in the hydrophilic block. Although all amphiphilic macromolecules inhibited unregulated uptake of hoxLDL by macrophages, inhibition efficiency was influenced by the quantity and location of the negatively charged-carboxylate on the macromolecules. Notably, negative charge is not the sole factor in reducing hoxLDL uptake. The combination of smaller size, micellar stability and charge density is critical for inhibiting hoxLDL uptake by macrophages.
format Text
id pubmed-2676825
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26768252009-05-12 Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture Wang, Jinzhong Plourde, Nicole M Iverson, Nicole Moghe, Prabhas V Uhrich, Kathryn E Int J Nanomedicine Original Research A series of novel amphiphilic macromolecules composed of alkyl chains as the hydrophobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively charged moieties (ie, carboxylic acids) located in the two different blocks. The macromolecules have molecular weights around 5,500 g/mol, form micelles in aqueous solution with an average size of 20–35 nm, and display critical micelle concentration values as low as 10(−7) M. Their charge densities and hydrodynamic size in physiological buffer solutions correlated with the hydrophobic/hydrophilic block location and quantity of the carboxylate groups. Generally, carboxylate groups located in the hydrophobic block destabilize micelle formation more than carboxylate groups in the hydrophilic block. Although all amphiphilic macromolecules inhibited unregulated uptake of hoxLDL by macrophages, inhibition efficiency was influenced by the quantity and location of the negatively charged-carboxylate on the macromolecules. Notably, negative charge is not the sole factor in reducing hoxLDL uptake. The combination of smaller size, micellar stability and charge density is critical for inhibiting hoxLDL uptake by macrophages. Dove Medical Press 2007-12 2007-12 /pmc/articles/PMC2676825/ /pubmed/18203436 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Original Research
Wang, Jinzhong
Plourde, Nicole M
Iverson, Nicole
Moghe, Prabhas V
Uhrich, Kathryn E
Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
title Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
title_full Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
title_fullStr Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
title_full_unstemmed Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
title_short Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
title_sort nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676825/
https://www.ncbi.nlm.nih.gov/pubmed/18203436
work_keys_str_mv AT wangjinzhong nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture
AT plourdenicolem nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture
AT iversonnicole nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture
AT mogheprabhasv nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture
AT uhrichkathryne nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture